Browse Drug Recalls
1,733 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 1,733 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 1,733 FDA drug recalls in 2015.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Feb 11, 2015 | DOXOrubicin Hydrochloride Injection, USP, 200 mg/100 mL (2 mg/mL), For IV Use... | Correct Labeled Product Mispack: Ifosfamide Injection 50 mg/mL, 60 mL, correctly labeled vial may... | Class III | Mylan Institutional LLC |
| Feb 10, 2015 | Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg, 90-count bottles,... | Failed Dissolution Specifications | Class II | Actavis Elizabeth LLC |
| Feb 6, 2015 | Antacid Liquid Regular Strength Antacid & Anti-Gas (Aluminum hydroxide 200 mg... | Microbial Contamination of Non-Sterile Products: Lots failed microbiological testing at the 12-mo... | Class II | Tarmac Products, Inc. |
| Jan 28, 2015 | Erythromycin Pledgets USP, 2%, 60-count jar,Rx only, Manufactured by Ei LLC, ... | Microbial Contamination of Non-Sterile Products: Active Pharmaceutical Ingredient (API) failed US... | Class II | Akorn, Inc. |
| Jan 28, 2015 | PHENYLephrine HCl, 60 mg added to 250 mL 0.9% Sodium Chloride Injection USP (... | Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride... | Class I | Pharmedium Services, LLC |
| Jan 28, 2015 | PHENYLephrine HCl, 50 mg added to 250 mL 0.9% Sodium Chloride Injection USP (... | Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride... | Class I | Pharmedium Services, LLC |
| Jan 28, 2015 | PHENYLephrine HCl, 20 mg added to 250 mL 0.9% Sodium Chloride Injection USP (... | Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride... | Class I | Pharmedium Services, LLC |
| Jan 28, 2015 | Fentanyl Citrate, 5 mcg per mL (1,250 mcg per 250 mL), 250 mL total volume in... | Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride... | Class I | Pharmedium Services, LLC |
| Jan 28, 2015 | PHENYLephrine HCl, 10 mg added to 250 mL 0.9% Sodium Chloride Injection USP (... | Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride... | Class I | Pharmedium Services, LLC |
| Jan 28, 2015 | PHENYLephrine HCl, 40 mg added to 250 mL 0.9% Sodium Chloride Injection USP (... | Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride... | Class I | Pharmedium Services, LLC |
| Jan 28, 2015 | Bupivacaine HCl 0.0625%, 250 mL total volume in a 250 mL LifeCare Bag in Sodi... | Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride... | Class I | Pharmedium Services, LLC |
| Jan 28, 2015 | Morphine Sulfate, 1 mg per mL (250 mg per 250 mL), 250 mL total volume in a 2... | Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride... | Class I | Pharmedium Services, LLC |
| Jan 26, 2015 | Compounded Plaquex, intravenous injection, 50 ML vial. Each ml contains: Ph... | Good Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from... | Class II | AnazaoHealth Corporation |
| Jan 25, 2015 | AMPD GOLD Bee Pollen capsules, 350 mg, 60-count bottle, Signature, 1027 Highw... | Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil, making... | Class I | Detox Transforms |
| Jan 25, 2015 | iNSANE Bee Pollen capsules, 200 mg, 60-count bottle, Developed by Signature, ... | Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared phenolphthalein an... | Class I | Detox Transforms |
| Jan 25, 2015 | EDGE Amplified Weight Release capsules, 400 mg, 60-count bottle, Developed by... | Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared phenolphthalein an... | Class I | Detox Transforms |
| Jan 25, 2015 | BtRiM Max capsules, 60-count bottle, Developed by Signature, 1027 Highway 70 ... | Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared phenolphthalein, m... | Class I | Detox Transforms |
| Jan 25, 2015 | iNDiGO capsules, 220 mg, 60-count bottle, Developed by Signature, 1027 Highw... | Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared phenolphthalein, m... | Class I | Detox Transforms |
| Jan 23, 2015 | Nicardipine Hydrochloride Injection, 25 mg/10 ml (2.5 mg/mL),10 mL single dos... | Subpotent Drug and Failed Impurities/Degradation Specifications | Class III | Mylan Institutional LLC |
| Jan 23, 2015 | KETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Via... | Crystallization | Class II | Hospira Inc. |
| Jan 23, 2015 | KETOROLAC Tromethamine Inj., USP, 30 mg (30 mg/mL), 1 mL Fill, Single-dose Vi... | Crystallization | Class II | Hospira Inc. |
| Jan 21, 2015 | Levetiracetam, extended release tablets, 750 mg, 60-count bottle, Rx only, Ma... | Failed Dissolution Specifications: 6 month time point. | Class II | Sun Pharma Global Fze |
| Jan 21, 2015 | Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 3 mL bottle, Rx only, Distr... | Presence of Particulate Matter: lot is not meeting the specification limit for number of particle... | Class II | Sun Pharma Global Fze |
| Jan 20, 2015 | 0.9% Sodium Chloride Injection, USP, 250 mL, Rx Only, Hospira Inc., Lake Fore... | Presence of Particulate Matter; Hospira has identified the particulate as a human hair, sealed in... | Class I | Hospira Inc. |
| Jan 20, 2015 | Avastin (Bevacizumab) 2 mg/0.08 mL syringe, Office Administration Only, AmEx ... | Non-Sterility: Product tested positive for bacterial contamination. | Class I | Pacifico National, Inc. dba AmEx Pharmacy |
| Jan 20, 2015 | Avastin (Bevacizumab) 1.25 mg/0.05 mL syringe, Office Administration Only, Am... | Non-Sterility: Product tested positive for bacterial contamination. | Class I | Pacifico National, Inc. dba AmEx Pharmacy |
| Jan 13, 2015 | fentaNYL Citrate, Preservative Free, 10 mcg per 1 mL In 0.9% Sodium Chloride,... | Subpotent Drug | Class I | Pharmedium Services, LLC |
| Jan 13, 2015 | fentaNYL Citrate, Preservative Free, 5 mcg per mL In 0.9% Sodium Chloride, 1 ... | Subpotent Drug | Class I | Pharmedium Services, LLC |
| Jan 12, 2015 | Daytrana (methylphenidate transdermal system), Delivers 30 mg over 9 hours (3... | Defective Delivery System: One lot exceeded the mechanical peel specification | Class II | Noven Pharmaceuticals, Inc. |
| Jan 8, 2015 | 5-methyltetrahydrofolate Calcium (L) (a) 1 gm in 2 oz container NDC: 52372-08... | Subpotent Drug | Class III | Freedom Pharmaceuticals Inc |
| Jan 6, 2015 | Practi-0.9% Sodium Chloride, 50 mL, 100 mL, 250 mL, 500 mL, and 1000 mL bags,... | Non-sterility: Product is made in a non-sterile facility and is not intended for use in humans or... | Class I | Wallcur Incorporated |
| Jan 6, 2015 | Benzonatate Capsules, USP, 100 mg, 100 count (10X10), Rx only, Packaged and D... | Failed Tablet/Capsule Specifications; recall initiated by manufacturer due to reports of wet caps... | Class II | American Health Packaging |
| Jan 2, 2015 | Glycopyrrolate injection, 0.2 mg per mL (1 mg/5 mL), 5 mL Fill in 10 mL Syrin... | Labeling: Incorrect or missing Lot and/or Exp Date: Printing error caused an overlap in the "y" a... | Class II | SCA Pharmaceuticals |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.